Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increlex in children with Crohn's disease
NCT00764699Phase 3Terminated
- Sponsor
- Nationwide Children's Hospital
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of mecasermin in Crohn's disease, sponsored by Nationwide Children's Hospital. Started Oct 2008; status: terminated.
02
Drugs
mecasermin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00764699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764699.